Premenstrual Disorders Linked to Broad Psychiatric Risk
Swedish study finds two-way associations between premenstrual disorders and psychiatric conditions, with strongest links involving depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, and personality disorders.
To examine the bidirectional associations between clinically diagnosed premenstrual disorders and various psychiatric disorders in a large Swedish cohort, emphasizing the reciprocal nature of these relationships.
Key Findings:
Women with premenstrual disorders had about twice the risk of developing psychiatric disorders, highlighting the importance of monitoring these patients.
48% of women with premenstrual disorders had a prior psychiatric diagnosis compared to 30% of controls, indicating a significant overlap.
37% of women with premenstrual disorders developed a subsequent psychiatric disorder during follow-up, underscoring the need for integrated care.
Bidirectional associations were observed for 13 of 14 psychiatric categories, particularly strong links to depression and anxiety disorders, suggesting shared underlying mechanisms.
Interpretation:
The findings suggest shared biological pathways, such as hormonal influences and neurotransmitter dysregulation, between premenstrual disorders and psychiatric conditions, indicating the need for sex-specific and menstrual cycle-informed psychiatric care.
Limitations:
Registry-based diagnoses may not confirm the criterion-standard diagnostic approach for premenstrual disorders, which could lead to underdiagnosis.
Timing of clinical diagnoses may not accurately reflect symptom onset, potentially skewing the association.
Potential surveillance bias and diagnostic misclassification due to symptom overlap may affect the reliability of the findings.
Conclusion:
The study underscores the importance of awareness among healthcare providers regarding the co-occurrence of premenstrual and psychiatric disorders, advocating for integrated and informed care strategies.
In a nationwide US cohort, parental subfecundity was associated with higher odds of autism spectrum disorder and modest increases in behavioral symptoms, while in vitro fertilization showed no statistically significant associations with neurodevelopmental outcomes.
Online interest in leucovorin, folate products, and acetaminophen-related autism concerns increased markedly in the 2 weeks following the White House announcement.
